Skip to product information
1 of 1

NorrChemica™

4,5-Dicyanoimidazole (DCI)

CAS 1122-28-7 ≥97%

4,5-Dicyanoimidazole (DCI) | CAS 1122-28-7 | ≥97%

Regular price €25,20 EUR (incl. VAT)
Regular price Sale price €25,20 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Weight
Quantity

Technical Specifications

CAS Number 1122-28-7
EC / EINECS Number 214-344-6
MDL Number MFCD00005194
SMILES C1=NC(=C(N1)C#N)C#N
InChI InChI=1S/C5H2N4/c6-1-4-5(2-7)9-3-8-4/h3H,(H,8,9)
InChIKey XGDRLCRGKUCBQL-UHFFFAOYSA-N
PubChem CID 70729
Molecular Formula C₅H₂N₄
Molecular Weight 118.1 g/mol
Melting Point 168–175 °C
Solubility Soluble in acetonitrile (1.8 g/10 mL, ~0.15 M; saturated ~1.1 M), DMSO, methanol
Log Pow -0.85
Purity ≥97%
Physical Form White to light yellow crystalline powder
HS Code 2933.29
Shelf Life Retest period: 36 months from date of manufacture
Storage Conditions Store in a cool, dry place in a tightly sealed container, protected from light

Product Description & Scientific Applications

4,5-Dicyanoimidazole (DCI; 1H-imidazole-4,5-dicarbonitrile) is a heterocyclic activator for nucleoside phosphoramidite coupling in solid-phase oligonucleotide synthesis and one of the best-established alternatives to 1H-tetrazole. With a pKa of about 5.2, DCI is less acidic than tetrazole yet more nucleophilic, shifting activator design away from simple protonation strength and toward faster nucleophilic displacement during phosphoramidite activation. In the original comparative study, DCI gave complete coupling in roughly half the time required with 1H-tetrazole. DCI dissolves in acetonitrile up to about 1.1 M at room temperature and can serve as the sole coupling activator in routine automated solid-phase oligonucleotide synthesis.

Phosphoramidite activation in oligonucleotide synthesis

DCI activates nucleoside phosphoramidite coupling to the 5'-hydroxyl group during automated solid-phase synthesis. Its lower acidity is useful where acid-promoted side reactions such as double addition are a concern, while its higher nucleophilicity supports rapid and efficient coupling. This is especially useful in scale-up work, where faster activation can help reduce phosphoramidite excess relative to tetrazole-based protocols. DCI is used with standard phosphoramidite monomers in automated oligonucleotide synthesis.

Modified-oligonucleotide synthesis

DCI has been used for the synthesis of modified oligonucleotides, including 2'-O-methoxyethyl phosphorothioate sequences used in antisense research. Studies comparing DCI- and tetrazole-activated couplings of these modified phosphorothioate oligonucleotides reported equivalent synthetic and analytical outcomes, supporting DCI as a substitute for tetrazole in demanding modified-oligonucleotide work.

Non-tetrazole alternative to 1H-tetrazole

DCI is used as a non-tetrazole activator where laboratories want to avoid the explosive-handling concerns associated with 1H-tetrazole while retaining efficient phosphoramidite coupling. This makes it attractive for routine automated synthesis and scale-up work where activator handling, solubility in acetonitrile, and coupling speed are practical constraints.

Phosphitylation and phosphoramidite monomer preparation

Beyond its role as a coupling activator, DCI is used in the preparation of phosphoramidite monomers themselves. It activates phosphorodiamidite reagents for selective phosphitylation of nucleoside hydroxyl groups, supporting the synthesis of standard and non-standard phosphoramidite building blocks used in oligonucleotide assembly.

Shipping Destinations

  • EU & UK only: 3–7 business days.
  • UK delivered DDP — duties and taxes prepaid; CoA & SDS included.

Safety Information

GHS Pictograms
GHS05 Corrosive GHS07 Harmful/Irritant
Signal Word Danger
Hazard Class None — not subject to transport regulations
Transport Category Not classified as dangerous goods for transport (ADR/IATA/IMDG)
H-Statements H315 - H318 - H335
P-Statements P261 - P264 - P271 - P280 - P302+P352 - P305+P351+P338 - P310 - P332+P313 - P362+P364 - P501

Documentation

Safety Data Sheet Download PDF
View full details